Telemonitoring for heart failure: The only feasible option for good universal care?

European Journal of Heart Failure

Volumn 11, Issue 3, 2009, Pages 227-228

  Cleland, John G F ^a,b   Lewinter, Christian ^a   Goode, Kevin M ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b Castle HillHospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; EDITORIAL; FOLLOW UP; HEALTH CARE; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART FAILURE; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION; TELEMONITORING; HOME CARE; METHODOLOGY; MONITORING; NOTE; ORGANIZATION AND MANAGEMENT; TELEMETRY;

HEART FAILURE; HOME CARE SERVICES; HUMANS; MONITORING, PHYSIOLOGIC; TELEMETRY;

EID: 65549162013     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp027     Document Type: Editorial

References (12)

1. Zhang J, Goode KM, Cuddihy PE, Cleland JGF. Predicting hospitalisation due to worsening heart failure using daily weight measurement: an analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) Study. Eur J Heart Fail 2009;11: in press.
2. Clark RA, Inglis SC, McAlister FA, Cleland JGF, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007;334:942.
3. Dar O, Riley J, Chapman C, Dubrey SW, Morris S, Rosen SD, Roughton M, Cowie MR. A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the HOME-HF study. Eur J Heart Fail 2009;11:319-325.
4. Mortara A, Pinna GD, Johnson P, Maestri R, Capomolla S, La Rovere MT, Ponikowski P, Tavazzi L, Sleight P on behalf of the HHH Investigators. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart failure). EurJ Heart Fail 2009;11:312-318.
5. Cleland JGF, Louis AA, Rigby AS, Janssens U, Balk AHMM, on behalf of the TEN-HMS investigators. Noninvasive Home Telemonitoring for Patients With Heart Failure at High Risk of Recurrent Admission and Death. The Trans-European Network-Home-Care Management System (TEN-HMS) Study. J Am Coll Cardiol 2005;45:1654-1664.
6. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ; DOT-HF steering committee and investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). EurJ Heart Fail 2008;10:907-916.
7. Cleland JG., Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey Programme: survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:424-463.
8. Cleland JG., Swedberg K., Cohen Solal A, Cosin-Aguilar J, Dietz R, Follath F, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Preda I, van Gilst WH, Widimsky J, Mareev V, Mason J, Freemantle N, Eastaugh J. The EuroHeart Failure Survey of the EUROHEART Survey Programme: a survey on the quality of care among patients with heart failure in Europe. Eur J Heart Fail 2000;2: 123-132.
9. Cleland JGF, Gemmel I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-241.
10. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I; VERITAS Investigators. Effects of tezosen-tan or symptoms and clinical outcomes in patients with acute heart failure. The VERITAS Randomized Controlled Trials. JAMA 2007;298:2009-2019.
11. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M; SURVIVE Investigators. Levosimendan vs. dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007;297:1883-1891.
12. Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on b-blockers in SURVIVE. EurJ Heart Fail 2009; 11:304-311.